Sitagliptin (Januvia™) is a new oral agent ... 1 Intent-to-treat population using last observation on study prior to metformin rescue therapy. *Least square means adjusted for prior ...

Researchers from the US have shown that combination therapy with sitagliptin and metformin results in a substantial and additive glycemic improvement in patients with type 2 diabetes. Sitagliptin ...

Zituvio and combination products include Zituvio (sitagliptin), Zituvimet (sitagliptin and metformin hydrochloride) and Zituvimet XR (sitagliptin and metformin hydrochloride) extended-release tablets.

The price of branded prescription drugs will rise an average of 4.5% in 2025, the same increase as was seen in 2024, according to one healthcare research company. At least 250 drugs will see list ...

These medications were sitagliptin, liraglutide, glimepiride, or insulin glargine U-100. Sitagliptin, liraglutide, and glimepiride increase the body’s insulin production in different ways, while ...

The latest verdict – in a federal appeals court – has upheld the validity of a key patent on sitagliptin, the active ingredient in Januvia, as well as metformin combinations Janumet and ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer class of drugs used to treat diabetes, have recently been ...

and sitagliptin/metformin (Janumet) "to align the list price more closely to the net price." (Reuters via Yahoo! News) At least 150 minutes of aerobic exercise per week was tied with clinically ...

Alibaba will sell its 78.7% stake in Sun Art Retail Group to DCP Capital for $1.58 billion, as part of its strategy to focus on core e-commerce operations. Branded prescription drug prices are ...

Serious side effects of metformin are rare. Less serious side effects, like digestive issues and headaches, are common, but these usually go away with time. You can reduce the chances of side ...

The combination of sitagliptin and metformin provided a more than additive effect on native GLP-1 concentrations. This combination may benefit patients with Type 2 diabetes through substantial ...

These three NDAs of Sitagliptin (base) and combination franchise had been approved by the USFDA earlier. (Image Credits: Pixabay) Zydus Lifesciences Ltd on Tuesday announced that it has entered ...